«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

25卷

期数:

2019年05期

页码:

440-445

栏目:

基础医学

出版日期:

2019-09-20

文章信息/Info

Title:

The value of ITSN1 mRNA in predicting the prognosis of breast cancer

文章编号:

1006-8147(2019)05-0440-06

作者:

张莹华; 马勇杰

（天津医科大学肿瘤医院肿瘤细胞生物学实验室，国家肿瘤临床医学研究中心，乳腺癌防治教育部重点实验室，天津市“肿瘤防治”重点实验室，天津市恶性肿瘤临床医学研究中心，天津 300060）

Author(s):

ZHANG Ying-hua; MA Yong-jie

（Laboratory of Tumor Cell Biology, Cancer Institute and Hospital，Tianjin Medical University, National Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education， Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’ s Clinical Research Center for Cancer，Tianjin 300060, China）

关键词:

ITSN1; HER2; 乳腺癌; 预后

Keywords:

ITSN1;  HER2;  breast cancer;  prognosis

分类号:

R737.9

DOI:

-

文献标志码:

A

摘要:

目的：通过数据库对ITSN1 mRNA的表达水平分析，以期能够预测乳腺癌患者的预后。方法:利用Kaplan- Meier Plotter数据库分析ITSN1 mRNA表达水平与乳腺癌患者预后的关系，GEPIA数据库分析基因ITSN1和HER2在乳腺癌中的表达。结果: ITSN1 mRNA高表达的乳腺癌总人群有更好的预后。ITSN1 mRNA的高表达预示luminal A、luminal B、HER2阴性、淋巴结阳性乳腺癌患者更长的无复发生存，以及淋巴结阴性乳腺癌患者更好的总生存。ITSN1 mRNA低表达的Her-2扩增型/阳性乳腺癌患者有更好的预后。ITSN1基因在乳腺癌中的表达低于正常乳腺组织，HER2基因在乳腺癌中的表达高于正常乳腺组织。结论：ITSN1 mRNA高表达的乳腺癌患者预后更好，ITSN1在乳腺癌中可能发挥抑癌的功能。

Abstract:

Objective: To predict the prognosis of breast cancer patients by analyzing the expression level of ITSN1 mRNA. Methods: The Kaplan-Meier Plotter database was used to analyze the relationship between ITSN1 mRNA expression and prognosis in breast cancer patients. The GEPIA database was applied to explore the expression of genes ITSN1 and HER2 in breast cancer. Results: The total population of breast cancer with high expression of ITSN1 mRNA had a better prognosis. High expression of ITSN1 mRNA predicted longer recurrence-free survival in patients with luminal A, luminal B, HER2-negative and node-positive breast cancer, and better overall survival in patients with node-negative breast cancer. Her-2 amplified/positive breast cancer patients with low ITSN1 mRNA expression had a better prognosis. The expression of ITSN1 gene in breast cancer was lower than that in normal breast tissue, and the expression of HER2 gene in breast cancer was higher than that in normal breast tissue. Conclusion: Breast cancer patients with high expression of ITSN1 mRNA have a better prognosis, and ITSN1 may play a role in tumor suppression in breast cancer.

参考文献/References:

[1] 翟寓.心理护理在急性脊髓损伤患者康复中的作用[J].当代护士(下旬刊),2017，5: 122
[2] Oleksandr Dergai, Mykola Dergai, Inessa Skrypkina, et al. The LMP2A protein of Epstein–Barr virus regulates phosphorylation of ITSN1 and Shb adaptors by tyrosine kinases [J]. Cellular Signalling, 2013, 25:33
[3] Predescu S, Bardita C, Predescu D, et al. New insights into the functions of intersectin-1s[J].Commun Integr Biol, 2015, 8(3):103 4400
[4] Bardita C, Predescu D N, Sha F, et al. Endocytic deficiency induced byITSN-1s knockdown alters the Smad2/3-Erk1/2 signaling balance downstream of Alk5[J].Cell Sci, 2015,128:1528
[5] Gu F, Zhang H, Qin F, et al. Intersectin1-S a multidomain adapter protein,is essential for malignant glioma proliferation[J].Glia,2015, 63:1595
[6] Russo A, O’Bryan J P. Intersectin1 is required for neuroblastoma tumorigenesis [J].Oncogene,2012,31:4828
[7] Herrero-Garcia E, O’Bryan J P. Intersectin scaffold proteins and their role in cell signaling and endocytosis[J].Biochim Biophys Acta Mol Cell Res, 2017,1864(1): 23
[8] Gryaznova T, Kropyvko S, Burdyniuk M, et al. Intersectin adaptor proteins are associated with actin-regulating proteinWIP in invadopodia [J]. Cell Signal, 2015, 27（7）：1499
[9] Kropyvko S, Gryaznova T, Morderer D, et al. Mammalian Verprolin CR16 acts as a modulator of ITSN scaffold proteins association with actin [J].Biochemi Biophys Res Commun, 2017, 484(4):813
[10] Novokhatska O, Dergai M, Tsyba L, et al. Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domain-containing proteins[J]. PLoS One, 2013, 8(7): e70546
[11] Ricciardi G R, Franchina T, Russo A, et al. Nab-paclitaxel and trastuzumab combination:a promising approach for neoadjuvant treatment in Her2-positive breast cancer[J]. Onco Targets Ther,2016,9:4351
[12] Olofsson S, Norrlid H, Karlsson E, et al. Societal cost of subcutaneous and intravenous trastuzumab for HER2-positive breast cancer e An observational study prospectively recording resource utilization in a Swedish healthcare setting[J]. Breast ,2016, 29:140
[13] 邵士珺，吴雪卿，万华等.乳癌术后方对HER2阳性乳腺癌复发转移小鼠NF-kB表达的影响[J].中国中西医结合杂志,2018,38(2):208
[14] 李慧，李春晓，南鹏，等.PI3K/AKT信号通路与HER2阳性乳腺癌患者总生存时间的相关性及验证分析[J].解放军医学杂志,2018， 43(3)：217
[15] Wheeler M，Domin J. The N-terminus of phosphoinositide 3-kinase-C2beta regulates lipid kinase activity and binding to clathrin[J]. J Cell Physiol, 2006, 206(3):586
[16] Harris M D, Herrero-Garcia E, Russo A, et al. Silencing Intersectin 1 Slows Orthotopic Neuroblastoma Growth in Mice[J]. Pediatr Hematol Oncol，2017，39(8):413
[17] Russoa A, Okurb M N, Bosland M, et al. Phosphatidylinositol 3-kinase, Class 2 beta(PI3KC2β) isoform contributes to neuroblastoma tumorigenesis[J].Cancer Lett，2015，359(2):262

相似文献/References:

[1]张莹华 综述,马勇杰 审校.ITSN1蛋白磷酸化的研究进展[J].天津医科大学学报,2019,25(06):666.
[2]张宁,金嘉琪,张少璐,等.ITSN1基因与卵巢癌化疗敏感性和预后的关系[J].天津医科大学学报,2023,29(04):354.
　ZHANG Ning,JIN Jia-qi,ZHANG Shao-lu,et al.Association of ITSN1 gene with chemosensitivity and prognosis in ovarian cancer[J].Journal of Tianjin Medical University,2023,29(05):354.

备注/Memo

备注/Memo:

基金项目 国家自然科学基金面上项目（81572851）
作者简介 张莹华（1990-）女，硕士在读，研究方向：生物化学与分子生物学；通信作者：马勇杰，E-mail:yongjiemagu@aliyun.com。

常用功能

更新日期/Last Update: 2019-10-11